1. Stone R et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med 2017; 377: 454-64.
2. Larson R et al. ASH 2017, Abstract #145.
3. Döhner H et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017; 129: 424-47.
4. Döhner K et al. ASH 2017, Abstract #467.
5. Perl AE et al. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: A multicentre, first-in-human, open-label, phase 1-2 study. Lancet Oncol 2017; 18: 1061-75.
6. Pratz K et al. ASH 2017, Abstract #722.
7. DiNardo CD et al. ASH 2017, Abstract #725.
8. Cheson B et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003; 21: 4642-9.
9. Stein EM et al. ASH 2017, Abstract #726.
10. Ravandi F et al. ASH 2017, Abstract #815.
11. Huls G et al. ASH 2017, Abstract #463.
12. Wei A et al. ASH 2017, Abstract #890.
13. ClinicalTrials.gov No. NCT03069352.
14. Lancet JE et al. J Clin Oncol 2016; 34 (S15): ASCO 2016, Abstract #7000.
15. Borthakur G et al. ASH 2017, Abstract #892.
16. Jongen-Lavrencic M et al. ASH 2017, Abstract #LBA-5.
17. Lo-Coco F et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 2013; 369: 111-21.
18. Platzbecker U et al. Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial. J Clin Oncol 2017; 35: 605-12.
19. Platzbecker U et al. ASH 2017, Abstract #2618.
20. Sanz MA et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96:1247-53.
21. Biccler Jl et al. ASH 2017, Abstract #2595.
22. Zhu H et al. ASH 2017, Abstract #1340.
23. Cicconi L et al. ASH 2017, Abstract #147.